-
Experts will discuss the importance of considering identity to enhance diabetes care
Among the speakers, Elise Van Laere will give an overview of responses to an illness identity questionnaire that explores multiple ways individuals relate to their diabetes, and the impact those have on diabetes-specific and psychosocial outcomes.
-
Debate will tackle optimal method for tracking burden and severity of hypoglycemia
Gregg Simonson, PhD, and other experts will review the evidence, share their insights, and engage in a robust debate highlighting objective measurements of hypoglycemia as well as subjective patient-reported events.
-
Speakers will highlight timely topics in nutrition and diabetes
Dietitian Maya Feller, MS, RD, CDN, and other experts will examine people’s relationships with food, as well as how low-carb, low-fat, and plant-based diets affect disease management and overall health.
-
Scientists to discuss multi-faceted approach to managing CV risk in people with diabetes and ASCVD
Irl Hirsch, MD, and other speakers will highlight considerations related to lipid management, glycemic metrics, and inflammation in this population, including clinical considerations not currently addressed in standard treatment guidelines.
-
Welcome to the 85th Scientific Sessions
A Friday morning welcome session at McCormick Place Convention Center will kick off the world’s largest diabetes conference and four days of networking opportunities and education showcasing “the full spectrum of diabetes science, from fundamental discoveries to preclinical research, clinical trials, and emerging therapies and technologies,” said Marlon Pragnell, PhD, the ADA’s Vice President of…
-
Symposium to highlight first ADA Standards of Care for Overweight and Obesity
Fatima Cody Stanford, MD, MPH, MPA, MBA, MACP, and others will detail some of the considerations for the management of these chronic conditions, including weight stigma and pharmacotherapy options. The new standards of care will be published later this year.
-
Panel will discuss approaches for screening and primary prevention of ASCVD in diabetes
Ian H. de Boer, MD, MS, and other panelists will explore blood pressure targets, glucose-lowering drugs, aspirin use, various screenings, and their roles in preventing and diagnosing atherosclerotic cardiovascular disease.
-
Speakers will explore intersection of circadian biology and diabetes
Experts, including Satchidananda Panda, PhD, will discuss the role of the circadian clock in modulation of beta cell function and glucose homeostasis, and spotlight the benefits of time-restricted eating.
-
Session to review strengths and limitations of CGMs and their data
Michael Kohn, MD, MPP, and other experts will delve into the controversies surrounding continuous glucose monitoring and its overall positive impact on the care for people with diabetes.
-
Cardiovascular Complications of Long Term Diabetes—Type 1 vs. Type 2
Robert H. Eckel, MD, previews a presentation at the 85th Scientific Sessions. Attendees in Chicago can watch the session in-person Monday, June 23, at 3:15 p.m. CT.